These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 2427398

  • 1. [The vascular wall and fibrinolysis--pathologic aspects].
    Fuchs U, Graff J.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):176-83. PubMed ID: 2427398
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S.
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The mechanisms of canalisation in deep vein thrombosis.
    Sevitt S.
    J Pathol; 1973 Jun; 110(2):153-65. PubMed ID: 4125876
    [No Abstract] [Full Text] [Related]

  • 8. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion.
    Trotti R, Siragusa S, Rondanelli M, Chezzi L, Citterio A, Melzi d'Eril GV, Piovella F.
    Haematologica; 1997 Jun; 82(2):178-81. PubMed ID: 9175322
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Quantitative determination of tissue-type plasminogen activator in varicose soleus veins].
    de Cossart L.
    Phlebologie; 1987 Jun; 40(4):1021-8. PubMed ID: 3128802
    [Abstract] [Full Text] [Related]

  • 14. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.
    Bu C, Zhang C, Li Z, Gao L, Xie Z, Cai G.
    Clin Exp Immunol; 2007 Jul; 149(1):31-9. PubMed ID: 17425656
    [Abstract] [Full Text] [Related]

  • 15. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
    Ueshima S, Matsuno H, Hayashi M, Horibuchi K, Okada K, Fukao H, Uematsu T, Matsuo O.
    Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.
    Panahloo A, Yudkin JS.
    J Cardiovasc Risk; 1997 Apr; 4(2):91-9. PubMed ID: 9304490
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.